Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
Background: Multidrug-resistant tuberculosis (MDR-TB) has remained a major global public health concern over the years due to the morbidity and mortality associated with the disease. The prolonged duration of drug treatment and adverse drug reactions (ADRs) may affect the compliance and eventually t...
Saved in:
Main Authors: | Abhishek Saini, Snehal Jadhav |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
Series: | Journal of Advanced Lung Health |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jalh.jalh_58_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India
by: Hindol Mondal, et al.
Published: (2025-07-01) -
The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline
by: Muhamad Frendy Setyawan, et al.
Published: (2024-01-01) -
Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01) -
Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-09-01) -
Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance
by: N. Yu. Nikolenko, et al.
Published: (2023-07-01)